Saturday, December 13, 2025 | 05:10 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Amid Covid surge, govt approves stepping up of production of Remdesivir

Govt aims to ramp up the production capacity for manufacturing of the drug to around 7.8 million vials per month

Hetero, remdesivir, Covifor, coronavirus, covid, vaccine, drugs, pharma
premium

Manufacturers of Remdesivir have volunteered to reduce the price to less than Rs 3,500 by the end of this week, says govt

BS Web Team
In order to curb the coronavirus surge in the country, Central government on Friday approved ramping up of production of the drug Remdesivir, used to treat Covid-19, which includes diverting 400,000 vials meant for export for domestic use. 

"The issue of availability of Remdesivir was reviewed by Mansukh Mandaviya, Minister of State for Chemicals & Fertilizers, in meetings with the all-existing manufacturers of the Remdesivir drug and other stakeholders, where decisions have been taken to increase production/supply and reduce prices of Remdesivir," said Ministry of Chemicals and Fertilizers in a statement.

The current total installed capacity of the seven manufacturers